日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Insights Into the Antigenic Repertoire of Unclassified Synaptic Antibodies

对未分类突触抗体抗原库的深入了解

Gilligan, Michael; Mills, John R; Vargas, Paulina; Paramasivan, Naveen K; Lesnick, Connie E; Basal, Eati; Dasari, Surendra; Fryer, James P; Hinson, Shannon R; Laporta, Joseph; Espinal, Amy; Fitzgerald, Dennis; Garcia, Carolina; Morenkova, Anna E; Pergami, Paola; Shah, Anna; Knight, Andrew; LaFrance Corey, Reghann; Lennon, Vanda A; Zekeridou, Anastasia; Pittock, Sean J; Dubey, Divyanshu; McKeon, Andrew

Autoimmune Neurobeachin Cerebellar Ataxia.

自身免疫性神经血管小脑共济失调

Basal Eati, Gilligan Michael, Lesnick Connie, McKeon Andrew

Utility of Protein Microarrays for Detection of Classified and Novel Antibodies in Autoimmune Neurologic Disease

蛋白质微阵列在自身免疫性神经系统疾病中已分类和新型抗体检测中的应用

McKeon, Andrew; Lesnick, Connie; Vorasoot, Nisa; Buckley, Monica W; Dasari, Surendra; Flanagan, Eoin P; Gilligan, Michael; Lafrance-Corey, Reghann; Miske, Ramona; Pittock, Sean J; Scharf, Madeleine; Yang, Binxia; Zekeridou, Anastasia; Dubey, Divyanshu; Mills, John

Progression and survival of MBL: a screening study of 10 139 individuals

MBL的进展和生存情况:一项纳入10139名受试者的筛查研究

Slager, Susan L; Parikh, Sameer A; Achenbach, Sara J; Norman, Aaron D; Rabe, Kari G; Boddicker, Nicholas J; Olson, Janet E; Kleinstern, Geffen; Lesnick, Connie E; Call, Timothy G; Cerhan, James R; Vachon, Celine M; Kay, Neil E; Braggio, Esteban; Hanson, Curtis A; Shanafelt, Tait D

Single-cell analysis reveals immune dysfunction from the earliest stages of CLL that can be reversed by ibrutinib

单细胞分析揭示了慢性淋巴细胞白血病早期阶段的免疫功能障碍,而伊布替尼可以逆转这种功能障碍。

Purroy, Noelia; Tong, Yuzhou Evelyn; Lemvigh, Camilla K; Cieri, Nicoletta; Li, Shuqiang; Parry, Erin M; Zhang, Wandi; Rassenti, Laura Z; Kipps, Thomas J; Slager, Susan L; Kay, Neil E; Lesnick, Connie; Shanafelt, Tait D; Ghia, Paolo; Scarfò, Lydia; Livak, Kenneth J; Kharchenko, Peter V; Neuberg, Donna S; Olsen, Lars Rønn; Fan, Jean; Gohil, Satyen H; Wu, Catherine J

Polygenic risk score and risk of monoclonal B-cell lymphocytosis in caucasians and risk of chronic lymphocytic leukemia (CLL) in African Americans

多基因风险评分与白种人单克隆B细胞淋巴细胞增多症风险以及非洲裔美国人慢性淋巴细胞白血病(CLL)风险的关系

Kleinstern, Geffen; Weinberg, J Brice; Parikh, Sameer A; Braggio, Esteban; Achenbach, Sara J; Robinson, Dennis P; Norman, Aaron D; Rabe, Kari G; Boddicker, Nicholas J; Vachon, Celine M; Lesnick, Connie E; Call, Timothy G; Brander, Danielle M; Rassenti, Laura Z; Kipps, Thomas J; Olson, Janet E; Cerhan, James R; Kay, Neil E; Furman, Richard R; Hanson, Curtis A; Shanafelt, Tait D; Slager, Susan L

The CLL International Prognostic Index predicts outcomes in monoclonal B-cell lymphocytosis and Rai 0 CLL

CLL国际预后指数可预测单克隆B细胞淋巴细胞增多症和Rai 0 CLL的预后。

Parikh, Sameer A; Rabe, Kari G; Kay, Neil E; Call, Timothy G; Ding, Wei; Leis, Jose F; Kenderian, Saad S; Muchtar, Eli; Wang, Yucai; Koehler, Amber B; Schwager, Susan M; Lesnick, Connie E; Kleinstern, Geffen; Van Dyke, Daniel; Hanson, Curtis A; Braggio, Esteban; Slager, Susan L; Shanafelt, Tait D

Measurable residual disease does not preclude prolonged progression-free survival in CLL treated with ibrutinib.

可测量的残留病灶并不妨碍接受伊布替尼治疗的慢性淋巴细胞白血病患者获得较长的无进展生存期

Wang Xin Victoria, Hanson Curtis A, Tschumper Renee C, Lesnick Connie E, Braggio Esteban, Paietta Elisabeth M, O'Brien Susan, Barrientos Jacqueline C, Leis Jose Francisco, Zhang Cong Christine, Coutre Steven E, Barr Paul M, Cashen Amanda F, Mato Anthony R, Singh Avina K, Mullane Michael P, Erba Harry, Stone Richard, Litzow Mark R, Tallman Martin S, Shanafelt Tait D, Kay Neil E

Upregulation of AXL and β-catenin in chronic lymphocytic leukemia cells cultured with bone marrow stroma cells is associated with enhanced drug resistance

在与骨髓基质细胞共培养的慢性淋巴细胞白血病细胞中,AXL 和 β-catenin 的上调与耐药性的增强相关。

Sinha, Sutapa; Secreto, Charla R; Boysen, Justin C; Lesnick, Connie; Wang, Zhiquan; Ding, Wei; Call, Timothy G; Kenderian, Saad J; Parikh, Sameer A; Warner, Steven L; Bearss, David J; Ghosh, Asish K; Kay, Neil E

Akt inhibitor MK-2206 in combination with bendamustine and rituximab in relapsed or refractory chronic lymphocytic leukemia: Results from the N1087 alliance study

Akt抑制剂MK-2206联合苯达莫司汀和利妥昔单抗治疗复发或难治性慢性淋巴细胞白血病:N1087联盟研究结果

Larsen, Jeremy T; Shanafelt, Tait D; Leis, Jose F; LaPlant, Betsy; Call, Tim; Pettinger, Adam; Hanson, Curtis; Erlichman, Charles; Habermann, Thomas Matthew; Reeder, Craig; Nikcevich, Daniel; Bowen, Deborah; Conte, Michael; Boysen, Justin; Secreto, Charla; Lesnick, Connie; Tschumper, Renee; Jelinek, Diane; Kay, Neil E; Ding, Wei